Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis

  1. 11Precigen, Inc. Germantown, MD , USA
  2. 2Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
  3. 3Precigen, Inc., Germantown, MD, USA

Related

  1. Allergen Immunotherapy and 36‐Month Allergic Respiratory Disease Trajectories: A Target‐Trial
    Víctor Gonzalez‐Uribe, Sebastian Moreno‐Castro, Viviana Cardoso‐Perez +5
    Immunity, Inflammation and DiseasePeer-reviewedCC BY 4.0Full textImmunologyPMC
  2. 47 AI-assisted cytometry panel design for cancer immunotherapy
    Li-Chun Cheng, Ramji Srinivasan, Landon Wellendorf
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYImmunologyOncologyDOAJ
  3. Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting
    Rong Wang, Yi Chen, Yan-fen Fang
    Acta Pharmacologica SinicaPeer-reviewedLicence not statedFull text2 citedImmunologyPMC
  4. Exploring tumor-derived exosomes as promising antigenic platforms: novel vaccine and immunotherapy strategies for “cold” colorectal cancer
    Xiaoting Liu, Xiaoyan Wang
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  5. CAR-macrophage immunotherapy targeting fibroblast-like synoviocytes ameliorates inflammatory and degenerative arthritis
    Y. Xu, Z. Wang, D. Xie +3
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
BibTeX
@article{sabzevari2026zopapogene,
  title = {{524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis}},
  author = {Helen Sabzevari and Amy Lankford and Gaetano Bonifacio and Scott M Norberg and Roshanak T Semnani and Tasha B Tan and David M Dalton and Premkumar V Giridhar and Clint T Allen},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0524},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0524},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis
AU  - Helen Sabzevari
AU  - Amy Lankford
AU  - Gaetano Bonifacio
AU  - Scott M Norberg
AU  - Roshanak T Semnani
AU  - Tasha B Tan
AU  - David M Dalton
AU  - Premkumar V Giridhar
AU  - Clint T Allen
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0524
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0524
SN  - 2051-1426
ER  -